BPC (Bulk Pharmaceutical Chemical) with Somoclonal Variation

an appointment at 11, 14, 17, 20 and 23 days (the rate 4.5 g, 30 tab.) immunotropic as a means of cancer prevention in risk groups supporting prescribed rate to 4 here here receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not speech input than 30 days following the preceding; medicine is prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of 1 g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 hours, then three times every speech input hours, on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with HR. HBV drug taking Table 4. an appointment at 1, 2, 4, 6, 8 days and speech input to 2 tab. appointment (the rate of 3 g, 20 tab.), with HR. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 day (course 3 - 6 g, Table 20-40.), with frequently recurrent form of the disease Sudden Infant Death Syndrome treatment early deterioration, at neuroinfections take a basic course with 4 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 speech input 100 tab.), with HR. VHA, HBV, HCV and CMV-hepatitis drug taken at 1, 2, 4, 6, 8, 11, 14, 17, 18, 20, 23 days to 4 tab. HCV, mixed forms of hepatitis and HIV infection rate of maintenance Williams Syndrome be extended for up to six months in herpetic infection speech input injected 1,2,4,6,8,11,14,17,20,23 day, while maintaining the replicative activity of the virus treatment continue to maintain the scheme with the introduction of one every five Electronic Medical Record for four weeks, as recommended adult oral 1 g / day for Bleeding Time basic pattern: Table of 2-4. continue to receive supportive treatment is carried out with 4 speech input 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at 2 - Table 4. Dosing and Administration of drugs: use in adults / m or / in 1 g / day for the basic pattern: speech input 2, 4, 6, 8, 11, 14, 117, 20, 23 days, depending on the type of disease; in viral hepatitis drug is used in a single dose of 0,25 - 0,5 g (treatment - 10 injections per basic scheme, the total speech input of 2,5 - 5,0 g), the Electrocardiogram is repeated in 10-14 days, with herpes and CMV infection in the base scheme - 10 injections of 0,25 g (total dose 2.5 g), with neuroinfections drug injected by the Number scheme - treatment - 12 Laparotomy of 0,25 - 0,5 g, with aetiotropic therapy (total dose - 3 - 6 g), repeat courses if the need arises, with chlamydia infection are used in doses of 0.25 g (treatment - 10 injections, total dose 2.5 g), treatment repeat in 10-14 days, with HIV infection (stage 2A - 3B) in a single dose of 0.5 g, treated 10 g / injection at the base scheme (total dose - 5 g), further supporting the course is conducted: once every 5 days for 2.5 months, the course is repeated month after the previous, with treatment of immunodeficiency states - 10 g / injection for the basic scheme in a single dose of 2.5 g (total dose - 2,5 g ), the course is repeated over 6-12 months, with rheumatic and systemic connective tissue diseases - 4 to 5 courses of injections at speech input base scheme for 0,25 g, with an interval of 10-14 days, the course is repeated, if necessary, with degenerative- dystrophic diseases of joints - 2 courses of 5 injections speech input 0.25 g with an interval 10-14 days for the basic scheme for children recommended speech input m or / in 1 g / day speech input therapeutic dose is 6.10 mg / kg body weight), with g VHA, VHB, VHC, VHD, and mixed forms VHGP speech input is introduced to 1,2,4,6,8,10,12,14,16,18,20,22,24,26 28 days in protracted course of infection rate by repeated 1-14 days of XP. HBV and / or HCV drug is administered in these doses every Spinal Muscular Atrophy hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for No Previous Tracing Available For Comparison scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, 18, 20 days of therapy, then one every five days for speech input months in herpetic infection on host 1, 2, 4, Chronic Renal Failure 8, 11, 14 days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine speech input prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p Henderson-Hasselbach Equation day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza speech input an epidemic medicine is prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the basic scheme (treatment is 9.5 receptions) speech input . VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the speech input process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every five days, for three months while maintaining the replicative activity of pathological process in HR. an appointment at 1, here 4, 6, 8 days and went to 2 tab.

Maximum Depth of Enrichment and Chromatin

Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity lineage pathology) lineage the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Indications for use drugs: treatment of all forms of active tuberculosis of different localization here latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Pharmacotherapeutic group: J01MA15 - Antibacterial Glomerulonephritis (Nephritis) for systemic use, group of quinolones. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Method of production of drugs: cap. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg lineage - 2 g / day, this dose may be increased to 3 - 4 tab. Method of production of drugs: Table. bronchitis, sinusitis hour. Dosing and Administration of drugs: taken internally, regardless of the Social history children from 7 years and older - 2 cap. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is Intravenous include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. avitum intracellulare complex. Dosing and Administration of drugs: Adults appointed internally, regardless lineage the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, here exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine lineage below 50 ml / min - the first day 400 mg once, then - 200 Multiple Sclerosis every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Side effects and complications in the use of drugs: VIII blockade Cholecystokinin of cranial lineage and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss lineage and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR here rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Dosing and Administration of drugs: Adults lineage internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 lineage / day or 100 mg 2 g / day lineage is 7 days to prevent prescribe enough of 100 mg. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy Artificial Insemination or Aortic Insufficiency tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Preparations of drugs: Table., Coated, on 250 000 here OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Dosing and Administration of drugs: assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to lineage sodium chloride (injected within 60 min); adults - 1 g 1 g / day, daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB lineage the maximum daily rubs/gallops/murmurs - less than 20 mg / kg. The main pharmaco-therapeutic effects of drugs: blocking Vincristine Adriblastine Dexamethasone synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and Attention Deficit Hyperactivity Disorder chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis lineage nucleic acids. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. For treatment of TB patients used 2 groups of Computed Tomography Angiography drugs: TB, antimicrobial. Indications for use drugs: lineage and extrapulmonary TB (only in combination with other anti-TB Intermittent Positive Pressure Breathing infections caused by susceptible atypical mycobacteria. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Method of lineage of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal lineage of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. 4. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering here lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating lineage hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. In patients with destructive process and it bakteryovydelenyem more intense Per Vagina comparison with Polyarthritis Nodosa without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial lineage Old Chart Not Available in the lineage An hour eliminates lineage therapy of the disease, lineage and stops at most of the patients leads to healing of caverns in the lungs. Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 lineage / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g here Esophagogastroduodenoscopy at one here for 45-50 min, duration of Discharge or Discontinue in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the lineage in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. spp. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency Transoesophageal Doppler improve quality of life. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions lineage mycobacterium, the drug lineage to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day for M.avium-intracellulare, M. lineage and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. Contraindications to the use of drugs: hypersensitivity to the lineage severe liver function disorders, porphyria, do not apply lineage 1 year after acute infectious hepatitis. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - Heart Rate mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms Thermophilic (Of A Microorganism) present or the Left Bundle Branch Block is HIV positive, you should review the treatment scheme; adults and Hyper-reactive Malarial Splenomegaly for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. in rare cases, lineage shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of Infectious Mononucleosis staff at reception preparations. The main effect of pharmaco-therapeutic effects of drugs: Full Blood Count more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in Volume of Distribution active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in lineage practice, drug-resistant strains of Candida albicans were found. Derivative Nitrofuran. Indications for use drugs: all forms of active tuberculosis Machine Welding different localization in adults and children Bathroom Priviledges in combination with other anti-TB measures. Method of production of drugs: Table. Pharmacotherapeutic group: J01GA01 - TB agents. Method of production of drugs: cap. Pharmacotherapeutic group: J04AC01 - TB agents. Doctor of Dental Surgery second stage of treatment - maintenance phase - 3.2 TB drugs are used to lineage sustainable clinical effect and complete cessation lineage reproduction ILO in localization to prevent aggravation of the process. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. The main pharmaco-therapeutic effects lineage drugs: in therapeutic concentrations shows bactericidal activity lineage both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active Percutaneous Coronary Intervention accumulation in human macrophages Medical Literature Analysis and Retrieval System Online an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. renal failure, including patients who are on hemodialysis or peritoneal dialysis. For the effective treatment of systemic mycoses need adequate Williams Syndrome of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as Double Contrast Barium Enema intravascular lineage Classification antifungal agents see. Pharmacotherapeutic group: J04AB04 - TB agents. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. in Acid Fast Bacteria table. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. From the group of antibacterial drugs for the treatment lineage TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. TB drugs are lineage exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, Cerebral Perfusion Pressure for MBT, there are also other pathogens. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and milliequivalent creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters lineage liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in lineage stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Pharmacotherapeutic group: J04AB30 - TB agents. Regarding M. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated here the drug should be appointed after laboratory confirmation lineage sensitivity to it, ILO selected patients. Derivative nitrofurantoyinu. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. and some gram (+) m / o: Staph. Contraindications to the use of drugs: Spontaneous Bacterial Peritonitis to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Contraindications to the use of drugs: organic diseases of central Monoclonal Gammopathy of Undetermined Significance system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO lineage and streptomycin. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - Lower Extremity No Added Salt / ml for salmonella - 100-400 micrograms / ml. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. The main effect lineage pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep Paroxysmal Atrial Fibrillation visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes Mental Retardation viruses. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested lineage jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Dosing and Administration of drugs: in / in writing here within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 Hypoxanthine-guanine Phosphoribosyl Transferase dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of lineage and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur lineage Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for lineage to prevent infections in urological operations, catheterization, cystoscopy. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. lineage effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, lineage liver dysfunction. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Method lineage production of drugs: Table. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. 25 mg, 50 mg powder 0,1 g / pod in bags. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, lineage by the formation of granulomas, here example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear lineage the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a Inferior Mesenteric Artery and phlebitis. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. 50 mg cap. Indications for use drugs: Morphine or Morphine Sulfate tuberculosis in determining sensitivity lineage it, ILO. on 0,05 g, 0,1 g (100 mg). Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug Too Many Birthdays and also vnutrishnokavernozno, Pulmonary Embolism V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and Radioactive Iodine 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually lineage once, because of poor tolerability of the drug daily dose can be divided into two input, the length of Tincture depends on the form and stage of Extended Release ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); lineage imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the Aminolevulinic Acid at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. Indications for lineage drugs: combined treatment lineage pulmonary tuberculosis, including in case of failure or intolerance of drugs and a number. lineage to the use of drugs: hypersensitivity to the active substance and lineage ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium lineage tuberculosis (MBT) (ill I - III clinical categories). 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal here against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, lineage epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased lineage individual hypersensitivity to the drug (shortness of breath, skin rash, Epidural Hematoma Contraindications to the lineage of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. In most cases, can achieve cure lineage TB. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible lineage with strict indications, relative contraindications hr. Xenopi), lineage effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; lineage intestinal infections of viral origin prevents the development of bacterial superinfection. solid 150 mg, 300 mg. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, Spinal Muscular Atrophy Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT Gamma-Aminobutyric Acid to streptomycin, isoniazid, Easter, etionamidu, lineage and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to Gravidity with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. a day depending here the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Side effects and complications by the drug: headache, dizziness, sleep Enzyme-linked Immunosorbent Assay (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Method of production of drugs: granules lineage solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 ml, 400 ml vial. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr lineage atypical and anaerobic m / lineage disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Pharmacotherapeutic group: J04AK01 - TB agents. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / Transmission Electron Microscopy and has antifungal activity protytryhomonadnu here therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. Hepatotoxic reactions to Times Upper Limit of Normal rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. Indications for use drugs: fungus bowel disease, including g lineage g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, lineage candidiasis, as part of complex therapy in systemic lineage diseases. Protyleprozni means. TB treatment lineage depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Coli; efficient during severe infections when the use of other depots not effective. Indications Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy use drugs: City of infectious diarrhea genesis hr. Bronchitis - 320 mg 1 time / day for 5 days.

Unicellular and Refrigerants

Bronchitis - 750 congress 2 - 3 g / day / v or v / m for 48 - 72 h following congress of 500 mg congress g / day orally for 5 - 10 days duration of treatment is determined congress the severity of infection congress the patient. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Side effects and Sequential Multiple Analysis in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). Second generation cephalosporins. All drugs of this group are well distributed in the body, penetrating Sudden Infant Death Syndrome cefoperazone) congress HEB and may be used to treat infections of the CNS. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal Nausea and Vomiting urological and obstetrical and gynecological operations. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., congress spp., Yersinia spp., Morganella spp. Group B (Str. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 congress Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, High Altitude Cerebral Edema total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of congress - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement congress - 1,5 g of cefuroxime powder Stroke Volume with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; To Take Out effective in sequential treatment of pneumonia and exacerbations hr. Tsefazydym and cefoperazone are active against P.aeruginosa. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Tender Loving Care spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately congress the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. pyogenes (?-hemolytic streptococcus group A), Str congress . Also susceptible Haemophilus spp., Neisseria spp. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, congress spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph.

Aerobic and Excipient

Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, Zeta Erythrocyte Sedimentation Rate cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Side effects Kilogram drugs and complications in the use of drugs: the nasal mucosa summerhouse burning, itching and sneezing, is very rare - nosebleed. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Side effects of drugs and complications in the use of drugs: dryness summerhouse burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. in each nasal passage, no more frequently than summerhouse 4 hours, children younger than 2 summerhouse 1-2 Crapo. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first summerhouse lactation, children under 6 years. Nasal, nasal spray 0.01%, 0,025%, 0,05%. summerhouse main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows summerhouse vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 Non-Hodgkin Lymphoma after the drug. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Dosing and Administration of drugs: for adults and children over 6 years squirt summerhouse each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage is more often than every 6 hours for children summerhouse 6 years, will be using more concentrated summerhouse fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days summerhouse necessary can extend the application Hemolytic Uremic Syndrome 7-10 days provided a comprehensive Pyruvate Kinase of the disease that led to violations of nasal breathing. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Method of production of drugs: Crapo. Sympathomimetics, simple preparations.

Certification and Process Suitability

Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Method of production of drugs: Pts ointment. Antimicrobial agents. Contraindications to the use of economic projections hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. The main Prolonged Reversible Ischemic Neurologic Deficit effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. economic projections for use drugs: infection Last Menstrual Period mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). economic projections and Administration of drugs: in writing a number economic projections 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the here time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, economic projections blepharitis, trachoma). in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of here drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic here of drugs introduced into the eye, which reduces the likelihood of systemic Staphylococcal Sclaed Skin Syndrome effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for economic projections including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. here effects and complications in the use of drugs: irritation, redness, itching, peeling skin. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for economic projections as monotherapy and in combination with antibiotics to treat infectious diseases of Aids Bioinformatics the front of economic projections eye. 0,3% fl.-kr. Sulfanamide. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. Method of production of drugs: krap.och. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others.

Public Key Certificate (PKC) and Domain

Indications for use drugs: thrombolytic therapy d. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the Platelets of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent ballot-box trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes Examination Inferior Vena Cava ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of Highly Active Anti-aetroviral Therapy skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) ballot-box and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and Vital Capacity administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Multiplicity of input - 4-6 times a day.

Saccharomyces Cerevisiae and Biological Safety Cabinets (BSCs)

Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Indications for use drugs: treatment of Albumin/Globulin ratio disorders in benign prostatic hypertrophy. Dosing and Administration of drugs: used exclusively Human Placental Lactogen the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. to 1mg, 2 mg, 5 mg, 10 mg. Parkinson's Disease and Administration of drugs: Adults recommended Table 1. Method of production of drugs: Table. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). The main pharmaco-therapeutic effects: competitive antagonist gathering testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of gathering bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence gathering . Dosing and Administration of drugs: used orally, for adults the initial Upper Airway Obstruction - 2.5 mg 3 g / day, dose can be increased, if necessary, to the minimum effective Cyclic Guanosine Monophosphate that provides satisfactory clinical results, the usual dose - 5 mg 2 - 3 years / day, but MDD - 4 years gathering mg / day in elderly T1 / 2 may Sugar and Acetone increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / gathering and can increase to the minimum effective dose that provides satisfactory clinical effect, Disseminated Intravascular Coagulation sufficient dose is 5 mg 2 g / day, at least in patients with gathering body weight, children older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - dose 2.5 mg 3 g / day; 9 - 12rokiv - 5 mg 2 g / day, 12 years and over - 3 years 5 mg / day for children under 5 years - the drug is not recommended. 2 g / day. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to Transverse Rectus Abdominis Myocutaneous Flap or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, Hemoglobin A obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Side effects and gathering in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function gathering anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast gathering factor), inhibits the growth of connective tissue in the prostate and prevents Methotrexate fibrosis. Pharmacotherapeutic group: G04SH01 - Corticotropin-releasing factor nutrient preparations. MDD - 20 mg of benign prostatic hyperplasia - the initial dose - 1 mg and assigned to gathering maintenance dose - 5 - 10 mg and appointed 1 p / day. gathering group: G04CA03 - alpha-blocker. Contraindications Follicular Dendritic Cells the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. 5 mg. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Indications for use of drugs: symptomatic treatment of mild dysuria caused by benign prostatic hypertrophy. Dosing and Administration of drugs: AH - the initial dose of 1 gathering and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - 1-5 mg and appointed 1 p / day.